About RX Melanotan 2: An Independent Research Digest

What this site is

RX Melanotan 2 is an independent editorial project that publishes plain-English summaries of the peer-reviewed research literature on Melanotan 2 (Melanotan II, MT-2). We read the published record, lead with the sexual-function studies that defined this peptide's early science, state the numbers plainly, and trace every figure to its source.

We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

About the 'rx' in the name

The 'rx' in our name is editorial framing, not a claim about services. It signals the question this site exists to answer honestly — people arrive at a name like this expecting either a storefront or a clinic, and the truthful answer is neither. We do not prescribe, dispense, recommend, or sell anything. We do not offer consultations or treatment. We hold no inventory and process no orders.

What the 'rx' actually marks is a posture toward the literature: a measured, data-forward reading of what the studies recorded, including the parts that are uncomfortable — the small sample sizes, the case reports of serious harm, the absence of any regulatory approval.

How we handle the evidence

We separate three things and never let them blur. Cited clinical and case-report findings are attributed to their studies. Community-reported effects are labeled anecdotal and kept clearly apart from the trial data. Mechanistic or theoretical cautions are flagged as theoretical, not presented as proven clinical outcomes.

We report doses only as facts about the studies that used them, never as guidance, because Melanotan 2 has no approved human use. Where the safety literature documents harm — renal injury, priapism, changing moles, melanoma — we report it plainly and cite it. Where the evidence is thin, we say so.

Corrections

If a citation here is inaccurate or out of date, we want to correct it. The literature on this compound is still accumulating — recent case reports continue to appear — and we update the digest as the record changes. Use the contact page to flag an error in a citation or a claim.